• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Semler Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events

    5/23/25 8:00:12 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SMLR alert in real time by email
    0001554859false00015548592025-05-232025-05-23

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    ​

    Date of Report (Date of earliest event reported): May 23, 2025

    SEMLER SCIENTIFIC, INC.

    (Exact name of registrant as specified in its charter)

    ​

    Delaware

        

    001-36305

        

    26-1367393

    (State or other jurisdiction of
    incorporation)

     

    (Commission File Number)

     

    (IRS Employer Identification No.)

    ​

    ​

    51 E Campbell Ave, Suite 107-D
    Campbell, CA

        

    95008

    (Address of principal executive offices)

     

    (Zip Code)

    ​

    Registrant’s telephone number, including area code: (877) 774-4211

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    ​

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    Title of each class

       

    Trading 
    Symbol(s)

        

    Name of each exchange on which registered

    Common Stock, $0.001 par value per share

     

    SMLR

     

    The Nasdaq Stock Market LLC

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company  ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    ​

    ​

    ​

    Item 7.01. Regulation FD Disclosure.

    Bitcoin Dashboard

    ​

    Semler Scientific, Inc. (Semler Scientific) maintains a dashboard on its website, www.semlerscientific.com, as a disclosure channel to provide broad, non-exclusionary distribution of information regarding Semler Scientific’s Bitcoin holdings to the public. Some of the information distributed through the website dashboard may be considered material information. Semler Scientific intends to use this website dashboard as a means of complying with its disclosure obligations under Regulation FD. The website dashboard will include information regarding market data for Semler Scientific’s common stock and Bitcoin, BTC Yield, BTC Gain and BTC $ Gain KPIs, Bitcoin purchases, Bitcoin holdings, and other related information. Investors and others are encouraged to regularly review the information that Semler Scientific makes public via the website dashboard.

    ​

    Furnished Information

    The information contained in this Item 7.01 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, or the Securities Act, except as shall be expressly set forth by specific reference in such filing.

    Item 8.01. Other Events.

    ATM Update

    On April 15, 2025, Semler Scientific, entered into a Controlled Equity OfferingSM Sales Agreement with Barclays Capital Inc., Cantor Fitzgerald & Co., Canaccord Genuity LLC, Needham & Company, LLC, Craig-Hallum Capital Group LLC and Lake Street Capital Markets, LLC, pursuant to which it may issue and sell from time to time up to $500.0 million of its common stock in an at-the-market (ATM) offering program. As of May 22, 2025, Semler Scientific has issued and sold 3,003,488 shares of its common stock for an aggregate net proceeds of approximately $114.8 million under this sales agreement.

    BTC Update

    Between May 13, 2025 and May 22, 2025, Semler Scientific acquired 455 Bitcoin for $50.0 million with an average purchase price of $109,801 per Bitcoin, inclusive of fees and expenses, using proceeds from its ATM offering program. As of May 22, 2025, Semler Scientific held 4,264 Bitcoin, which were acquired for an aggregate of $390.0 million at an average purchase price of $91,471 per Bitcoin, inclusive of fees and expenses and had a market value of $474.4 million based on the price of Bitcoin as reported on the Coinbase exchange as of 4:00 p.m. ET on such date.

    BTC Yield as a Key Performance Indicator (KPI)

    Semler Scientific’s BTC Yield was 25.8% YTD through May 22, 2025. Semler Scientific uses BTC Yield as a KPI to help assess the performance of its strategy of acquiring Bitcoin in a manner Semler Scientific believes is accretive to stockholders. Semler Scientific believes this KPI can be used to supplement an investor’s understanding of Semler Scientific’s decision to fund the purchase of Bitcoin by issuing additional shares of its common stock or instruments convertible to common stock.

    ​

    ​

    ​

    ​

    ​

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ​

     

    SEMLER SCIENTIFIC, INC.

     

     

     

    Date: May 23, 2025

    By:

    /s/ Renae Cormier

     

     

    Name: Renae Cormier

    ​

    ​

    Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

    ​

    ​

    ​

    ​

    Get the next $SMLR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SMLR

    DatePrice TargetRatingAnalyst
    11/2/2022$60.00 → $45.00Buy → Neutral
    B. Riley Securities
    3/7/2022$145.00 → $70.00Buy
    B. Riley Securities
    11/2/2021$175.00 → $145.00Buy
    B. Riley Securities
    10/26/2021$151.00 → $175.00Buy
    B. Riley Securities
    More analyst ratings